ArticleJAC-antimicrobial resistance2025
Training future antimicrobial stewards in the ESCMID AMS certificate training programme: from knowledge to action.
Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Drug-Resistant Infections in Burn Patients: A One-Year Analysis of Microbiological Trends and Predictive Risk Factors in a Romanian Tertiary Care Centre.Antibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: ESCMID has established the Antimicrobial Stewardship (AMS) Certificate programme to provide healthcare professionals with AMS expertise. This study evaluated the effectiveness of this 2-year training programme, measuring knowledge, skills and tangible results. Participants and methods: This observational cohort study included participants in the first AMS certificate programme, which started in June 2022. The programme included online and live courses covering relevant AMS learning goals. Participants also carried out a local AMS project using a determinant analysis with pre- and post-intervention measurements. Data were collected through surveys, exams, and an evaluation of mandatory reports to assess progress across Kirkpatrick's four levels of learning: reaction, learning, behaviour and results. Results: Forty participants from 22 countries took part in the programme. Individual courses were positively evaluated (reaction, level 1). All participants passed the final exam (learning, level 2). After 2 years, 35/40 (88%) submitted their AMS project reports (behaviour, level 3). In 31/35 (89%) of projects a post-intervention measurement was performed, of which 26/31 (84%) showed a positive effect on either process outcomes (e.g. increase in guideline adherence), quantity outcomes (e.g. reduced broad-spectrum antibiotic use), or patient outcomes (e.g. length of stay) (results, level 4). Conclusions: The ESCMID AMS certificate programme effectively transfers knowledge and skills to participants who intend to develop ASPs in different clinical settings. Moreover, the course prompted the development and execution of local AMS projects with measurable impact on appropriate antibiotic use practices.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.